IQVIA Holdings Inc. filings document a NYSE-listed operating company with common stock under the IQV symbol and a business centered on clinical research services, commercial insights and healthcare intelligence. Form 8-K reports document quarterly and annual operating results, segment disclosures for R&D Solutions and Commercial Solutions, share repurchase authorizations and amendments to the company's credit agreement.
Proxy and governance filings describe annual meeting matters, director elections and appointments, executive compensation, equity incentive plans and stockholder voting items. The filings also provide formal records of capital-structure terms, material agreements and board oversight for IQVIA's life sciences and healthcare services business.
IQVIA Holdings executive Bernd Haas reported equity-based compensation activity. On February 8, 2026, he acquired 8,265 shares of common stock at $0 upon achievement of performance goals tied to restricted stock units granted in 2023. The company’s Leadership Development and Compensation Committee certified that these performance conditions were satisfied on that date. On the same day, 440 shares were withheld at a price of $187.49 to cover obligations associated with the award, leaving Haas with 24,414 IQVIA common shares held directly following the transactions. He serves as EVP, AI and Technology Solutions.
IQVIA Holdings Inc. officer Alistair Grenfell reported equity compensation activity involving the company’s common stock. On February 8, 2026, he acquired 11,795 shares of common stock at $0 per share, bringing his holdings to 29,669 shares directly owned.
On the same date, a separate transaction coded F covered the disposition of 5,545 shares at $187.49 per share, after which he directly owned 24,124 shares of IQVIA common stock. The acquired shares were delivered upon achievement of performance conditions under performance-based restricted stock units granted on February 13, 2023.
IQVIA Holdings executive Michael J. Fedock reported equity transactions in company common stock. On February 8, 2026, he acquired 6,735 shares at $0, tied to performance-based restricted stock units whose conditions were confirmed achieved by the Leadership Development and Compensation Committee.
Fedock also disposed of 111 shares on February 7, 2026 and 2,420 shares on February 8, 2026, each at a price of $187.49 per share. After these transactions, he directly beneficially owned 9,595 shares of IQVIA common stock.
IQVIA Holdings officer Bhavik Patel reported equity award activity in company stock. On February 8, 2026, he acquired 4,083 shares of common stock at a price of $0, following satisfaction of performance conditions tied to performance-based restricted stock units granted on February 13, 2023.
On the same date, a separate transaction reduced his direct holdings by 1,920 shares at $187.49 per share, leaving him with 3,203 shares of IQVIA common stock held directly.
IQVIA Holdings executive Eric Sherbet reported equity transactions tied to performance-based awards. On February 8, 2026, he acquired 6,806 shares of common stock at $0, delivered upon the achievement of performance criteria for restricted stock units granted on February 13, 2023.
On the same date, 1,915 shares were disposed of at $187.49 per share, consistent with a share withholding transaction typically used to cover tax obligations. After these transactions, Sherbet directly held 25,999 shares of IQVIA common stock.
IQVIA Holdings executive W. Richard Staub reported two equity-related transactions in common stock on February 8, 2026. He received a grant of 2,722 shares at no cost, reflecting performance-based restricted stock units originally granted on February 13, 2023, after the Leadership Development and Compensation Committee determined the performance conditions were satisfied on February 8, 2026. On the same date, 806 shares were delivered to cover tax obligations at $187.49 per share. Following these transactions, Staub directly holds 18,812 shares of IQVIA common stock.
IQVIA Holdings reported that officer Keriann Cherofsky received 1,087 shares of common stock on February 8, 2026 at $0 per share. These shares were earned after performance conditions tied to performance-based restricted stock units granted on February 13, 2023 were certified as satisfied by the company’s Leadership Development and Compensation Committee.
On the same date, 415 shares of common stock were disposed of at $187.49 per share, leaving Cherofsky with 3,547 shares of IQVIA common stock held directly after the reported transactions.
IQVIA Holdings executive vice president and chief financial officer Ronald E. Bruehlman reported equity transactions in company common stock on February 8, 2026. He acquired 16,335 shares at $0 per share upon achievement of performance criteria tied to performance-based restricted stock units granted on February 13, 2023, after the company’s Leadership Development and Compensation Committee determined those conditions were satisfied.
On the same date, he disposed of 6,801 shares of common stock in a transaction coded “F” at $187.49 per share. Following these transactions, Bruehlman directly owned 44,103 shares of IQVIA common stock and indirectly owned an additional 11,893 shares through the Ronald E. Bruehlman Revocable Trust.
IQVIA Holdings executive James G. Berkshire reported equity compensation activity. On February 8, 2026, he acquired 2,722 shares of common stock at $0.00 per share upon achievement of performance criteria tied to performance-based restricted stock units granted on February 13, 2023.
On the same date, 1,280 shares of common stock were disposed of at $187.49 per share, leaving him with 8,177 shares of IQVIA common stock held directly. The award’s performance conditions were confirmed as satisfied by the company’s Leadership Development and Compensation Committee on February 8, 2026.
IQVIA Holdings Inc. Chairman, Chief Executive Officer & President Ari Bousbib reported equity-related transactions in the company’s common stock on February 8, 2026. He acquired 57,177 shares at $0 when performance conditions on previously granted performance-based restricted stock units were certified as achieved by the Leadership Development and Compensation Committee. On the same day, 28,399 shares were disposed of at $187.49 in a transaction coded “F,” indicating shares were withheld to cover taxes. Following these transactions, he directly owned 835,941 common shares and indirectly held 543,302 shares through the Orohena Trust.